This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Net Issues 2013 Earnings Guidance

Health Net, Inc. (NYSE:HNT) today announced its 2013 annual guidance of $2.00 to $2.10 for GAAP earnings per diluted share.

Health Net expects its consolidated revenues for the combined Western Region Operations (Western Region) and Government Contracts segments in 2013 will be between approximately $10.7 billion and $11.2 billion.

Compared with year-end 2012 enrollment, the company expects the following with regard to year-end 2013 enrollment for the Western Region:
  • Total health plan membership will decline by 1 to 2 percent;
  • Commercial enrollment will decline by 8 to 9 percent;
  • Medicare Advantage enrollment will increase by 1 to 2 percent; and
  • Medicaid enrollment will increase by 4 to 6 percent.

Western Region commercial premium yields per member per month (PMPM) in 2013 are expected to increase by approximately 3.6 percent compared with 2012.

The year-over-year change in commercial premium yields PMPM is anticipated to be affected by ongoing product and geographic mix shifts. In 2013, the company expects commercial enrollment to be more heavily weighted to smaller accounts and tailored network products that have lower than company-average premiums PMPM when compared with 2012.

Western Region commercial health care costs PMPM in 2013 are expected to increase by approximately 350 basis points less than the 2013 increase in commercial premium yields PMPM.

The company expects the year-over-year change in commercial health care costs PMPM to be driven by several factors. The company anticipates no recurrence of adverse prior period development in 2013, which accounts for approximately 200 basis points of the change noted above. The continuing mix shift from larger to smaller groups, from higher cost to lower cost geographies, and from full network products to more efficient products with lower medical care ratios, is expected to account for approximately 90 basis points of the difference. Lastly, approximately 60 basis points of the difference are expected to result from repricing actions in the company’s largest accounts.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs